Muhaba Kejela
Dados Biográficos
| ID | 9801658 |
|---|---|
| NOME | Muhaba Kejela |
| PRENOMES | Muhaba |
| SOBRENOME | Kejela |
| ASSINATURA | KEJELA M |
| AFILIAÇÕES | Arba Minch University |
| VERIFICADO | Não |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2026 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia
BACKGROUND: remains a major challenge for malaria control programmes. Novel regimens, such as 7-day high-dose primaquine regimen and single-dose tafenoquine, may improve treatment adherence and antirelapse effectiveness but can increase the risk of haemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency. Stakeholder (ie, policymakers, providers, patients, etc) perceptions of these risks may significantly influence the acceptab…
Sem obras proeminentes nesta página.
Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia
BACKGROUND: remains a major challenge for malaria control programmes. Novel regimens, such as 7-day high-dose primaquine regimen and single-dose tafenoquine, may improve treatment adherence and antirelapse effectiveness but can increase the risk of haemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency. Stakeholder (ie, policymakers, providers, patients, etc) perceptions of these risks may significantly influence the acceptab…
Focus group (1 obras) · Malaria (1 obras) · Malaria Research and Control (1 obras) · Parasites and Host Interactions (1 obras) · Primaquine (1 obras) · Public health (1 obras) · Qualitative research (1 obras) · Regimen (1 obras) · Risk perception (1 obras) · Vector-borne infectious diseases (1 obras)